Scopus BioPharma Inc. (SCPS:OTC) closed at $0.000 on October 20, 2026, unchanged on the day. The stock trades 96.0% below its 52-week high of $0.010 and 300.0% above its 52-week low of $0.000. Scopus BioPharma Inc. is part of the Health Care sector.
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. The company product candidates would utilize synthetically-produced cannabinoids as opposed to plant-derived compounds. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.
Find more stocks like SCPS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.